C

CervoMed
D

CRVO

8.00000
USD
-0.18
(-2.20%)
مغلق
حجم التداول
3,379
الربح لكل سهم
-3
العائد الربحي
-
P/E
-3
حجم السوق
74,021,752
أصول ذات صلة المقالات

العنوان: CervoMed

القطاع: Healthcare
الصناعة: Biotechnology
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction,the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.